CORTEXYME
Cortexyme is a clinical stage pharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is currently testing several potential lead therapeutics in preclinical studies.
CORTEXYME
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2012-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.cortexyme.com
Total Employee:
11+
Status:
Active
Total Funding:
225 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Clene Nanomedicine
Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Praxis Precision Medicines
Praxis Precision Medicines offers drug development services.
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-10 | Novosteo | Novosteo acquired by Cortexyme | N/A |
Investors List
KG Investments
KG Investments investment in Post-IPO Equity - Cortexyme
Smallcap World Fund
Smallcap World Fund investment in Series B - Cortexyme
Vulcan Capital
Vulcan Capital investment in Series B - Cortexyme
Takeda Ventures
Takeda Ventures investment in Series B - Cortexyme
Breakout Ventures
Breakout Ventures investment in Series B - Cortexyme
Huizenga Capital Management
Huizenga Capital Management investment in Series B - Cortexyme
Dolby Family Ventures
Dolby Family Ventures investment in Series B - Cortexyme
EPIQ Capital Group
EPIQ Capital Group investment in Series B - Cortexyme
Lamond Family
Lamond Family investment in Series B - Cortexyme
Verily
Verily investment in Series B - Cortexyme
Key Employee Changes
| Date | New article |
|---|---|
| 2020-04-30 | Cortexyme Appoints Caryn McDowell, J.D. as Chief Legal and Administrative Officer and Corporate Secretary |
Official Site Inspections
http://www.cortexyme.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.92 K
- Host name: s3-website-us-west-1.amazonaws.com
- IP address: 52.219.221.19
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
